Physician profile

Jess Joymon

Thoracic Surgery (Cardiothoracic Vascular Surgery) · Denver, CO

NPI 1598916405

$34,802.65

in general payments reported to CMS, 2019-2025

37 companies · $1,364 in 2025

The $1,364 reported for 2025 was more than what a typical Thoracic Surgery (Cardiothoracic Vascular Surgery) provider received nationally (typical 2025 total: $796).

Payments by year

General payments by program year, as reported to CMS.

What the payments were for

Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.

View as a table
Payment typeAmount (2023-2025)
Food and Beverage$3,749.65
Travel and Lodging$2,871.62

Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.

Who reported paying

General payments only, as reported to CMS. Product names cover 2023-2025.

CompanyGeneral paymentsYearsTop products
Intuitive Surgical, INC. $18,470.31 2019-2020
Abiomed $4,432.32 2019-2025 Impella
Edwards Lifesciences Corporation $3,177.50 2019-2025 Mitris Resilia Mitral Valve, Konect Resilia, Edwards Sapien 3 Transcatheter Heart Valve (Thv)
Abbott Laboratories $2,644.62 2019-2025 Epic, Mitraclip, Navitor
Genentech USA, INC. $1,125.00 2020
Zimmer Biomet Holdings, INC. $1,037.39 2020-2025 Sternalock 360 System
Artivion, INC. $979.39 2019-2022
Bolton Medical INC $288.64 2019-2021
Atricure, INC. $279.88 2021-2025 Synergy Ablation System, Atriclip Laa Exclusion System
Angiodynamics, INC. $257.78 2021-2022
Medtronic, INC. $225.53 2025 Mc3 Nautilus(Tm) Ecmo Oxygenator, Corevalve Evolut R
Livanova USA, INC. $202.62 2022-2023 Protekduo, Lifesparc
Baxter Healthcare $184.18 2024-2025 Floseal, Preveleak
Astrazeneca Pharmaceuticals Lp $152.44 2021-2024 Wainua
Inari Medical, INC. $142.14 2024 Ct Thrombectomy System Kit, Flowtriever Catheter, S
Show all 37 companies
CompanyGeneral paymentsYearsTop products
Kci USA, INC. $122.13 2020
Shockwave Medical, INC $117.51 2023 Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter
Kls-Martin L.P. $116.18 2021
Veran Medical Technologies, INC. $112.54 2020
Genentech, INC. $93.35 2019
Ethicon INC. $78.15 2020
Ethicon US, LLC $76.07 2019
Cvrx, INC. $63.22 2024 Barostim Neo System
Depuy Synthes Sales INC. $53.21 2024 Matrixrib
Davol INC. $45.19 2023 Progel Applicator Spray Tips
Kiniksa Pharmaceuticals International, Plc $40.87 2024 Arcalyst
Janssen Pharmaceuticals, INC $40.71 2024 Xarelto
Dilon Technologies, INC. $40.65 2023 Hemoblast Bellows
Merck Sharp & Dohme LLC $39.28 2022-2024 Verquvo
Lsi Solutions INC $26.75 2024 Cor-Knot
Cerus Corporation $25.35 2023 Intercept Blood System For Platelets
Corcym INC $22.63 2025 Mi Detach - Aortic Cross Clamp - Delivery System Kit
Lexicon Pharmaceuticals, INC. $22.47 2023 Inpefa
E.R. Squibb & Sons, L.L.C. $19.11 2023 Opdivo
Kiniksa Pharmaceuticals, Ltd. $18.92 2023 Arcalyst
Esperion Therapeutics, INC. $17.82 2023 Nexletol
Covidien Lp $10.80 2019

Drugs and devices associated with these payments

CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.

If you want to bring it up

Most clinicians are glad to talk about this. A respectful way in:

These are normal questions. A good clinician will welcome them.

Share this page

Payment summary

Jess Joymon

$34,802.65

in general payments reported 2019-2025

Years
2019-2025
Top company
Intuitive Surgical, INC.
Context
The $1,364 reported for 2025 was more than what a typical Thoracic Surgery (Cardiothoracic Vascular Surgery) provider received nationally (typical 2025 total: $796).

https://glasscript.com/doctor/254261/jess-joymon

Source: CMS Open Payments, program years 2019-2025. Payments are legal and often routine.

Keep an eye on this page

Get an email when the next June refresh changes this page. No account needed.

Watch this doctor

Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.